Tag:#German medical cannabis

Demecan On-Track To Hit Early 2022 Harvest After Fund-Raising Boost

GERMANY’s sole domestic cannabis producer is expected to harvest its first crop in early 2022 after securing additional investment to complete its production facility. Demecan,...

German Medical Cannabis Milestone As First Homegrown Flowers Distributed To Patients

HOMEGROWN medical cannabis is now available to German patients for the first time. Aphria RX– a wholly-owned subsidiary of Canadian pharmaceutical and cannabis company Tilray...

Eurox To Launch First ‘Made In Germany’ Cannabis Derivatives Into The Domestic Market

THE first home-made medical cannabis products will debut on the German market within weeks. This comes as Eurox Group - the producer of the derivatives...

Huge Milestone As First German Cannabis Company Debuts On Stock Exchange

GERMANY has its first publicly-listed cannabis company in Cannovum, a Berlin-based importer wholesaler and distributor of medical cannabis. Co-founder Pia Marten described its listing on...

Curaleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC Move

FOLLOWING its recent acquisition of UK-firm EMMAC Life Sciences leading US player Curaleaf has wasted no time in expanding into Europe’s biggest medical cannabis...

Leading German Pharma Company Launches Medical Cannabis Range Into Fast-Growing Domestic Market

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products - and six more...

Eurox Pharma To Deliver The First ‘Made in Germany’ THC Oils Into The Domestic Market

AMBITIOUS medical cannabis company Eurox Pharma is just weeks away from launching the first domestically-produced THC oils into the German market. Despite having the most...

New European Ecosystem Highlights Emerging Opportunities For Cannabis Entrepreneurs

IN spite of its delayed arrival Europe has a first-class opportunity to become a world-leader in the emerging global cannabis industry. This is one of...

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...
- Advertisement -spot_imgspot_img

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...